Beneficial effects of the herbal medicine Di Huang Yin Zi in patients with spinal cord injury: A randomized, placebocontrolled clinical study

Journal of International Medical Research

Volumn 40, Issue 5, 2012, Pages 1715-1724

  Li, Yu Liang ^a   Li, L T ^b   Yu, M ^b   Wang, Y Z ^a   Ge, H Y ^c   Song, C Q ^b  

^a THE SECOND HOSPITAL OF SHANDONG UNIVERSITY   (China)

^b Shandong Medical College   (China)

^c AALBORG UNIVERSITY   (Denmark)

Author keywords

Alternative medicine; Chinese medicine; Complementary medicine; Di Huang Yin Zi (DHYZ); Functional recovery; Spinal cord injury

Indexed keywords

AGENTS ACTING ON THE PERIPHERAL NERVOUS AND NEUROMUSCULAR SYSTEMS; CHINESE DRUG; DI HUANG YIN ZI; PLACEBO; PLANT MEDICINAL PRODUCT; UNCLASSIFIED DRUG; HERBACEOUS AGENT;

ADULT; ARTICLE; BARTHEL INDEX; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DEEP VEIN THROMBOSIS; DEPRESSION; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; ELECTROCHEMICAL DETECTION; FEMALE; HERBAL MEDICINE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; MOTOR PERFORMANCE; MUSCLE STRENGTH; NAUSEA; OCCUPATIONAL THERAPY; PHYSIOTHERAPY; RANDOMIZED CONTROLLED TRIAL; SPINAL CORD FUNCTION; SPINAL CORD INJURY; TABLET PROPERTY; TREATMENT DURATION; UNSPECIFIED SIDE EFFECT; URINARY TRACT INFECTION; CHINESE MEDICINE; CONTROLLED CLINICAL TRIAL; CONVALESCENCE; MIDDLE AGED; NERVE REGENERATION; PARAPLEGIA; PATHOPHYSIOLOGY;

ADULT; DRUGS, CHINESE HERBAL; FEMALE; HUMANS; MALE; MEDICINE, CHINESE TRADITIONAL; MIDDLE AGED; NERVE REGENERATION; PARAPLEGIA; RECOVERY OF FUNCTION; SPINAL CORD INJURIES;

EID: 84880581624     PISSN: 03000605     EISSN: 14732300     Source Type: Journal    
DOI: 10.1177/030006051204000510     Document Type: Article

References (59)

1. Botterell EH, Jousse AT, Kraus AS, et al: A model for the future care of acute spinal cord injuries. Can J Neurol Sci 1975; 2: 361-380.
2. Kraus JF, Silberman TA, McArthur DL: Epidemiology of spinal cord injury. In: Principles of Spinal Surgery (Menezes AH, Sonntag VKH, Benzel EC, et al, eds). New York: McGraw-Hill, 1996; pp 41-58.
3. Staas WE, Formal CS, Freedman MK, et al: Spinal cord injury and spinal cord injury medicine. In: Rehabilitation Medicine: Principles and Practice, 3rd edn (DeLisa JA, Gans BM, eds). Philadelphia: Lippincott–Raven, 1998; pp 1259–1291.
4. Bracken MB: Treatment of acute spinal cord injury with methylprednisolone: results of a multicenter, randomized clinical trial. J Neurotrauma 1991; 8(suppl 1): S47-S50.
5. Bracken MB, Collins WF, Freeman DF, et al: Efficacy of methylprednisolone in acute spinal cord injury. JAMA 1984; 251: 45-52.
6. Bracken MB, Holford TR: Effects of timing of methylprednisolone or naloxone administration on recovery of segmental and long-tract neurological function in NASCIS 2. J Neurosurg 1993; 79: 500-507.
7. Bracken MB, Shepard MJ, Collins WF, et al: A randomized, controlled trial of methyl - prednisolone or naloxone in the treatment of acute spinal-cord injury. Results of the Second National Acute Spinal Cord Injury Study. N Engl J Med 1990; 322: 1405-1411.
8. Bracken MB, Shepard MJ, Collins WF Jr, et al: Methylprednisolone or naloxone treatment after acute spinal cord injury: 1-year follow-up data. Results of the Second National Acute Spinal Cord Injury Study. J Neurosurg 1992; 76: 23-31.
9. Bracken MB, Shepard MJ, Hellenbrand KG, et al: Methylprednisolone and neurological function 1 year after spinal cord injury. Results of the National Acute Spinal Cord Injury Study. J Neurosurg 1985; 63: 704-713.
10. Bracken MB, Shepard MJ, Holford TR, et al: Administration of methylprednisolone for 24 or 48 hours or tirilazad mesylate for 48 hours in the treatment of acute spinal cord injury. Results of the Third National Acute Spinal Cord Injury Randomized Controlled Trial. National Acute Spinal Cord Injury Study. JAMA 1997; 277: 1597-1604.
11. Bracken MB, Shepard MJ, Holford TR, et al: Methylprednisolone or tirilazad mesylate administration after acute spinal cord injury: 1-year follow up. Results of the Third National Acute Spinal Cord Injury Randomized Controlled Trial. J Neurosurg 1998; 89: 699–706.
12. Wong MK, Chen CF, Lien IN: Evaluation of the results of rehabilitation for spinal cord injuries over a recent 10-year period. Taiwan Yi Xue Hui Za Zhi 1981; 80: 433-441.
13. Wong AM, Leong CP, Su TY, et al: Clinical trial of acupuncture for patients with spinal cord injuries. Am J Phys Med Rehabil 2003; 82: 21–27.
14. Chen HY, Lin JM, Chuang HY, et al: Raffinee in the treatment of spinal cord injury: an openlabeled clinical trial. Ann N Y Acad Sci 2005; 1042: 396-402.
15. Seo TB, Han IS, Yoon JH, et al: Growthpromoting activity of Hominis Placenta extract on regenerating sciatic nerve. Acta Pharmacol Sin 2006; 27: 50-58.
16. Tsai CC, Lu MC, Chen YS, et al: Locally administered nerve growth factor suppresses ginsenoside Rb1-enhanced peripheral nerve regeneration. Am J Chin Med 2003; 31: 665–673.
17. Ao Q, Sun XH, Wang AJ, et al: Protective effects of extract of Ginkgo biloba (EGb 761) on nerve cells after spinal cord injury in rats. Spinal Cord 2006; 44: 662-667.
18. Xia WJ, Yang M, Fok TF, et al: Partial neuroprotective effect of pretreatment with tanshinone IIA on neonatal hypoxia–ischemia brain damage. Pediatr Res 2005; 58: 784-790.
19. Liao B, Newmark H, Zhou R: Neuroprotective effects of ginseng total saponin and ginsenosides Rb1 and Rg1 on spinal cord neurons in vitro. Exp Neurol 2002; 173: 224–234.
20. Donovan WH, Brown DJ, Ditunno JF Jr, et al: Neurological issues. Spinal Cord 1997; 35: 275-281.
21. State Pharmacopoeia Commission of the People’s Republic of China: Pharmacopoeia of the People’s Republic of China. Beijing: Chemical Industry Press, 2000.
22. Zhang ZJ, Kang WH, Tan QR, et al: Adjunctive herbal medicine with carbamazepine for bipolar disorders: a double-blind, randomized, placebo-controlled study. J Psychiatr Res 2007; 41: 360-369.
23. DeJong G, Branch LG, Corcoran PJ: Independent living outcomes in spinal cord injury: multivariate analyses. Arch Phys Med Rehabil 1984; 65: 66-73.
24. Dallmeijer AJ, van der Woude LH, Hollander AP, et al: Physical performance during rehabilitation in persons with spinal cord injuries. Med Sci Sports Exerc 1999; 31: 1330–1335.
25. Harkema SJ: Neural plasticity after human spinal cord injury: application of locomotor training to the rehabilitation of walking. Neuroscientist 2001; 7: 455-468.
26. Girgis J, Merrett D, Kirkland S, et al: Reaching training in rats with spinal cord injury promotes plasticity and task specific recovery. Brain 2007; 130: 2993-3003.
27. Tator CH, Koyanagi I: Vascular mechanisms in the pathophysiology of human spinal cord injury. J Neurosurg 1997; 86: 483-492.
28. Tator CH, Fehlings MG: Review of the secondary injury theory of acute spinal cord trauma with emphasis on vascular mechanisms. J Neurosurg 1991; 75: 15-26.
29. Demopoulos HB, Flamm ES, Pietronigro DD, et al: The free radical pathology and the microcirculation in the major central nervous system disorders. Acta Physiol Scand Suppl 1980; 492: 91-119.
30. Crowe MJ, Bresnahan JC, Shuman SL, et al: Apoptosis and delayed degeneration after spinal cord injury in rats and monkeys. Nat Med 1997; 3: 73-76.
31. Emery E, Aldana P, Bunge MB, et al: Apoptosis after traumatic human spinal cord injury. J Neurosurg 1998; 89: 911-920.
32. Cadotte DW, Fehlings MG: Spinal cord injury: a systematic review of current treatment options. Clin Orthop Relat Res 2011; 469: 732-741.
33. Chen HC, Hsieh MT, Chang SS, et al: Long-term reno-cardiovascular effects of orally administered Aconiti Tuber in humans. Am J Chin Med 1990; 18: 25-33.
34. Yanaga A, Goto H, Nakagawa T, et al: Cinnamaldehyde induces endothelium- dependent and -independent vasorelaxant action on isolated rat aorta. Biol Pharm Bull 2006; 29: 2415-2418.
35. Kubo M, Asano T, Shiomoto H, et al: Studies on Rehmanniae Radix. I. Effect of 50% ethanolic extract from steamed and dried Rehmanniae Radix on hemorheology in arthritic and thrombosic rats. Biol Pharm Bull 1994; 17: 1282–1286.
36. Yun YJ, Lee B, Hahm DH, et al: Neuroprotective effect of Palmul-Chongmyeong-Tang on ischemia-induced learning and memory deficits in the rat. Biol Pharm Bull 2007; 30: 337–342.
37. Nakajima S, Uchiyama Y, Yoshida K, et al: The effects of Ginseng Radix Rubra on human vascular endothelial cells. Am J Chin Med 1998; 26: 365-373.
38. Li TJ, Qiu Y, Mao JQ, et al: Protective effects of Guizhi-Fuling-Capsules on rat brain ischemia/reperfusion injury. J Pharmacol Sci 2007; 105: 34-40.
39. Lin Z, Yan Y, Zhu D, et al: Protective effects of FBD-an experimental Chinese traditional medicinal formula on memory dysfunction in mice induced by cerebral ischemia-reperfusion. J Ethnopharmacol 2005; 97: 477-483.
40. Bains M, Hall ED: Antioxidant therapies in traumatic brain and spinal cord injury. Biochim Biophys Acta 2012; 1822: 675-684.
41. Zheng SY, Sun J, Zhao X, et al: Protective effect of Shen-Fu on myocardial ischemia-reperfusion injury in rats. Am J Chin Med 2004; 32: 209-220.
42. Toda S: Inhibitory effects of aromatic herbs on lipid peroxidation and protein oxidative modification of mice brain homogenate by copper in vitro. Phytother Res 2001; 15: 541-543.
43. Yokozawa T, Chen CP, Tanaka T: Direct scavenging of nitric oxide by traditional crude drugs. Phytomedicine 2000; 6: 453-463.
44. Shimada Y, Yokoyama K, Goto H, et al: Protective effect of Keishi-bukuryo-gan and its constituent medicinal plants against nitric oxide donor-induced neuronal death in cultured cerebellar granule cells. Phytomedicine 2004; 11: 404-410.
45. Koo BS, Kim YK, Park KS, et al: Attenuating effect of a traditional Korean formulation, Paeng-Jo-Yeon-Nyeon-Baek-Ja-In-Hwan (PJBH), on hydrogen peroxide-induced injury in PC12 cells. Phytother Res 2004; 18: 488-493.
46. Peng Q, Wei Z, Lau BH: Fructus Corni enhances endothelial cell antioxidant defenses. Gen Pharmacol 1998; 31: 221-225.
47. Wu SJ, Ng LT, Lin CC: Antioxidant activities of some common ingredients of traditional Chinese medicine, Angelica sinensis, Lycium barbarum and Poria cocos. Phytother Res 2004; 18: 1008-1012.
48. Li H, Wang Q: Evaluation of free hydroxyl radical scavenging activities of some Chinese herbs by capillary zone electrophoresis with amperometric detection. Anal Bioanal Chem 2004; 378: 1801-1805.
49. Peng Q, Wei Z, Lau BH: Fructus Corni attenuates oxidative stress in macrophages and endothelial cells. Am J Chin Med 1998; 26: 291–300.
50. Yokozawa T, Liu ZW, Chen CP: Protective effects of Glycyrrhizae radix extract and its compounds in a renal hypoxia (ischemia)–reoxygenation (reperfusion) model. Phytomedicine 2000; 6: 439-445.
51. Collins WF: A review and update of experiment and clinical studies of spinal cord injury. Paraplegia 1983; 21: 204-219.
52. Li GL, Brodin G, Farooque M, et al: Apoptosis and expression of Bcl-2 after compression trauma to rat spinal cord. J Neuropathol Exp Neurol 1996; 55: 280-289.
53. Kim EH, Jang MH, Shin MC, et al: Protective effect of aqueous extract of Ginseng radix against 1-methyl-4-phenylpyridinium-induced apoptosis in PC12 cells. Biol Pharm Bull 2003; 26: 1668-1673.
54. Park YH, Son IH, Kim B, et al: Poria cocos water extract (PCW) protects PC12 neuronal cells from ??-amyloid-induced cell death through antioxidant and antiapoptotic functions. Pharmazie 2009; 64: 760-764.
55. Yu Y, Du JR, Wang CY, et al: Protection against hydrogen peroxide-induced injury by Zligustilide in PC12 cells. Exp Brain Res 2008; 184: 307-312.
56. Kim SC, Park SJ, Lee JR, et al: Cytoprotective activity of Glycyrrhizae radix extract against arsenite-induced cytotoxicity. Evid Based Complement Alternat Med 2008; 5: 165-171.
57. Shin HY, Chang IA, Zhang WJ, et al: Immune stimulatory effects of Loranthi ramulus on macrophages through the increase of NO and TNF-a. Immunopharmacol Immunotoxicol 2009; 31: 370-376.
58. Jian ZH, Chen CC, Lu HY, et al: Effects of Jiawey Siwu on rat activity. Am J Chin Med 2001; 29: 509-516.
59. Kirshblum S, Millis S, McKinley W, et al: Late neurologic recovery after traumatic spinal cord injury. Arch Phys Med Rehabil 2004; 85: 1811-1817.